Li et al., 2012 - Google Patents
Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobesLi et al., 2012
View HTML- Document ID
- 13241450895150154941
- Author
- Li L
- Zhang R
- Yin L
- Zheng K
- Qin W
- Selvin P
- Lu Y
- Publication year
- Publication venue
- Angewandte Chemie (International ed. in English)
External Links
Snippet
A general and versatile biomimetic approach to synthesize water dispersible and functionalizable upconverting nanoparticles (UCNPs) for selective imaging of live cancer cells is reported. The approach involves coating the surface of UCNPs with a monolayer of …
- 239000002105 nanoparticle 0 title abstract description 20
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes | |
| Zhao et al. | In situ synthesis of fluorescent mesoporous silica–carbon dot nanohybrids featuring folate receptor-overexpressing cancer cell targeting and drug delivery | |
| Zhang et al. | Exploring heterostructured upconversion nanoparticles: from rational engineering to diverse applications | |
| Su et al. | Cetuximab-conjugated iodine doped carbon dots as a dual fluorescent/CT probe for targeted imaging of lung cancer cells | |
| Tian et al. | Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs | |
| Ali et al. | Red fluorescent carbon nanoparticle-based cell imaging probe | |
| Wang et al. | Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy | |
| Liu et al. | Bioconjugated pluronic triblock-copolymer micelle-encapsulated quantum dots for targeted imaging of cancer: in vitro and in vivo studies | |
| Yao et al. | Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy | |
| Huang et al. | Application of paramagnetic graphene quantum dots as a platform for simultaneous dual-modality bioimaging and tumor-targeted drug delivery | |
| Zhou et al. | Mesoporous NaYbF4@ NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging | |
| Xiong et al. | Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors | |
| Zhang et al. | Dye-doped fluorescent silica nanoparticles for live cell and in vivo bioimaging | |
| Ma et al. | Folic acid-conjugated LaF3: Yb, Tm@ SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography | |
| Li et al. | Ratiometric monitoring of intracellular drug release by an upconversion drug delivery nanosystem | |
| Yang et al. | Ultrasmall and photostable nanotheranostic agents based on carbon quantum dots passivated with polyamine-containing organosilane molecules | |
| Guo et al. | LRET-based biodetection of DNA release in live cells using surface-modified upconverting fluorescent nanoparticles | |
| Gui et al. | N-Doped graphene quantum dot@ mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery | |
| Chen et al. | Studies on preparation of photosensitizer loaded magnetic silica nanoparticles and their anti-tumor effects for targeting photodynamic therapy | |
| Xu et al. | Tuning the properties of atomically precise gold nanoclusters for biolabeling and drug delivery | |
| Flak et al. | GQDs-MSNs nanocomposite nanoparticles for simultaneous intracellular drug delivery and fluorescent imaging | |
| Wang et al. | Lipid coated upconverting nanoparticles as NIR remote controlled transducer for simultaneous photodynamic therapy and cell imaging | |
| Lartigue et al. | Luminophore and magnetic multicore nanoassemblies for dual-mode MRI and fluorescence imaging | |
| Mangeolle et al. | The targeting ability of fluorescent quantum dots to the folate receptor rich tumors | |
| Kumar et al. | FITC-Dextran entrapped and silica coated gadolinium oxide nanoparticles for synchronous optical and magnetic resonance imaging applications |